Bevantolol hydrochloride is a novel selective β-adrenergic receptor blocker with high selectivity for β1-adrenergic receptors, along with mild α1-adrenergic receptor blocking activity and mild calcium channel antagonism; it is used for the treatment of hypertension and angina pectoris by reducing heart rate, myocardial contractility, and blood pressure.